Alnyam Pharmaceuticals (ALNY), which fell after reporting Q4 results last week, is down 4% AH...

|By:, SA News Editor

Alnyam Pharmaceuticals (ALNY), which fell after reporting Q4 results last week, is down 4% AH after filing to sell 7M shares, worth $86.7M based on today's close. The company, less than a month removed from announcing a major restructuring plan, says it will use the proceeds to help advance its drug pipeline, including its ALN-TTR02 and ALN-APC drugs.